InflaRx NV (IFRX)
1.55
-0.04
(-2.52%)
USD |
NASDAQ |
Oct 13, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
InflaRx EPS Diluted (TTM) : -0.6484 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6484 |
| March 31, 2026 | -0.6814 |
| September 30, 2025 | -0.9164 |
| June 30, 2025 | -0.958 |
| March 31, 2025 | -0.8948 |
| September 30, 2024 | -1.048 |
| June 30, 2024 | -0.8597 |
| March 31, 2024 | -0.7632 |
| December 31, 2023 | -0.8508 |
| September 30, 2023 | -0.745 |
| June 30, 2023 | -0.7877 |
| March 31, 2023 | -0.6199 |
| December 31, 2022 | -0.7097 |
| September 30, 2022 | -0.8522 |
| June 30, 2022 | -0.9934 |
| March 31, 2022 | -1.408 |
| December 31, 2021 | -1.271 |
| September 30, 2021 | -1.317 |
| June 30, 2021 | -1.285 |
| March 31, 2021 | -1.304 |
| December 31, 2020 | -1.433 |
| Date | Value |
|---|---|
| September 30, 2020 | -1.638 |
| June 30, 2020 | -1.969 |
| March 31, 2020 | -2.208 |
| December 31, 2019 | -2.290 |
| September 30, 2019 | -2.163 |
| June 30, 2019 | -1.850 |
| March 31, 2019 | -1.308 |
| December 31, 2018 | -1.369 |
| September 30, 2018 | -2.868 |
| June 30, 2018 | -3.235 |
| March 31, 2018 | -3.844 |
| December 31, 2017 | -3.926 |
| September 30, 2017 | -1.976 |
| June 30, 2017 | -1.301 |
| March 31, 2017 | -0.7437 |
| December 31, 2016 | -0.3819 |
| September 30, 2016 | -0.3819 |
| June 30, 2016 | -0.3819 |
| March 31, 2016 | -0.2114 |
| December 31, 2015 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -7.847 |
| Immatics NV | -1.849 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |